Pharmaceuticals and healthcare

moves, lateral hires and exits

Norton Rose hit with mass defection as 15-strong team exit to Reed Smith

A team of 15 lawyers across four different Norton Rose Fulbright offices in the US have decamped to join Reed Smith. The team includes global head of life sciences and healthcare Rick Robinson, Washington partner Lesley Reynolds, Austin partners Jeff Layne and Ben Koplin and New York partner Cori Goldberg. Two Norton Rose associates, Washington […]

Registration of medicines in the Eurasian Economic Union

At the Pharmaceutical Forum of the EAEU and CIS countries held in Moscow in late February 2018, the Director of the Department of Technical Regulation and Accreditation of the Eurasian Economic Commission (EEС) said that the full-scale work on registration of medicines using the unified information system of the Eurasian Economic Union (EAEU) will start […]

Vischer advises Lundbeck on acquisition of Prexton Therapeutics

Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under terms of the agreement, Lundbeck will pay €100m upfront and is furthermore required to later pay up to €805m in development and sales milestones to the group of current owners. VISCHER advised Lundbeck […]

Walder Wyss advises Auris Medical on reverse split

On March 12, 2018, the extraordinary general meeting of shareholders approved the merger of Auris Medical Holding AG, a Swiss company listed on Nasdaq, into Auris Medical NewCo Holding AG, a newly incorporated, wholly-owned Swiss Subsidiary. The Merger became effective on March 13, 2018, upon its registration in the Commercial Register in the Canton of […]

Khaitan & Co advises Torrent Pharmaceuticals on acquisition of Unichem businesses

Khaitan & Co advised Torrent Pharmaceuticals Limited in relation to acquisition financing facility of INR 2800 crores raised through a combination of loan and non-convertible debentures for the purpose of financing the acquisition of branded businesses of Unichem Laboratories Limited. Kumar Saurabh Singh (Partner), Soumava Chatterjee (Principal Associate) and Oindrila Bhowmik (Associate). Torrent Pharmaceuticals Limited, the flagship […]

Vischer advises Medartis on planned IPO on SIX Swiss Exchange

Medartis Holding AG, a leading original equipment manufacturer (OEM) specialized in medical devices for internal surgical bone fixation, announces its intention to conduct an initial public offering (IPO) on the SIX Swiss Exchange in the first half of 2018 to finance further growth. Founded in 1997 by Dr. h.c. Thomas Straumann, Medartis has emerged as […]

Vischer advises Polyphor on licensing agreement with Santhera

Polyphor AG, a clinical stage, privately held Swiss specialty pharma company, has entered into an exclusive, global license agreement with Santhera Pharmaceuticals to further develop and commercialize the inhaled neutrophil elastase inhibitor, POL6014, in Cystic Fibrosis (CF) and other neutrophilic lung diseases. Under the terms of the agreement, Polyphor will receive an upfront payment of […]

Daniel Brook, pharma litigation, Hogan Lovells

Brook, Daniel – Hogan Lovells

As a former chemistry student, Hogan Lovells IP partner Daniel Brook has honed his legal and science knowledge to become indispensable to several of the world’s largest pharmaceutical companies looking to safeguard their products. One of the most important judgments last year was Eli Lilly’s landmark patent trial against pharmaceutical rival Actavis. Brook took the […]

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email:

If you are looking for our Jobs site, please click here